{{Drugbox
| IUPAC_name = (4-methylpiperazin-1-yl)-(1-pentylindol-3-yl)methanone
| image = MEPIRAPIM_structure.png

<!--Clinical data-->
| tradename =  
| pregnancy_AU = 
| pregnancy_US = 
| pregnancy_category =  
| legal_AU = 
| legal_CA = Schedule II
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 
| ATC_prefix =  
| ATC_suffix =  
| PubChem = 101896603
| ChemSpiderID      = 52085735
| smiles            = CCCCCN1C=C(C2=CC=CC=C21)C(=O)N3CCN(CC3)C
| StdInChI          = 1S/C19H27N3O/c1-3-4-7-10-22-15-17(16-8-5-6-9-18(16)22)19(23)21-13-11-20(2)12-14-21/h5-6,8-9,15H,3-4,7,10-14H2,1-2H3
| StdInChIKey       = IUEFFEOHJKCBPF-UHFFFAOYSA-N

<!--Chemical data-->
| C=19 | H=27 | N=3 | O=1
| molecular_weight = 
}}

'''MEPIRAPIM''' is a [[indole]]-based [[cannabinoid]] which differs from [[JWH-018]] by having a 4-methylpiperazine group in place of the naphthyl group<ref>{{cite web | url=https://www.caymanchem.com/app/template/Product.vm/catalog/15388 | title=MEPIRAPIM | publisher=Cayman Chemical | accessdate=23 June 2015}}</ref> and has been used as an active ingredient in [[synthetic cannabis]] products. It was first identified in Japan in 2013, alongside [[FUBIMINA]].<ref name="Uchiyama_2014">{{cite journal | url=https://link.springer.com/article/10.1007%2Fs11419-013-0217-2 | title=Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products | journal=Forensic Toxicology | vauthors=Uchiyama N, Shimokawa Y, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y | date=January 2014 | volume=32 | issue=1 | pages=105–115 | doi=10.1007/s11419-013-0217-2}}</ref>

==Legality==

Sweden's public health agency suggested to classify MEPIRAPIM as hazardous substance on November 10, 2014.<ref>{{cite web | url=http://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2014/november/cannabinoider-foreslas-bli-klassade-som-halsofarlig-vara/ | title=Cannabinoider föreslås bli klassade som hälsofarlig vara  | accessdate=29 June 2015}}</ref>

==See also==
* [[APICA]]
* [[AM-2201]]
* [[JWH-073]]
* [[JWH-250]]
* [[JWH-200]]
* [[List of JWH cannabinoids]]
* [[List of AM cannabinoids]]
* [[THJ-2201]]

==References==
{{Reflist}}

{{Cannabinoids}}

[[Category:Indoles]]
[[Category:Cannabinoids]]
[[Category:Designer drugs]]
[[Category:Piperazines]]


{{nervous-system-drug-stub}}